Articles tagged with Cancer Treatments
Graduates can expect to earn nearly £670,000 more over their working life due to SES education. SES research is vital to tackling global health challenges like obesity, diabetes, and cancer.
Researchers have developed a novel compound that specifically targets the endoplasmic reticulum stress response in cancer cells, promoting apoptosis and inhibiting tumor growth. The compound can be precisely activated by UV irradiation and emits fluorescence, allowing real-time tracking of its activity.
Researchers developed cell membrane-coated nanocarriers to overcome immune clearance and biotoxicity issues. These biomimetic hybrids achieve improved biocompatibility, circulation time, and therapeutic efficiency.
Abnormal chromosome number abnormalities are linked to increased risk of lethal disease in prostate cancer patients. Patients with five or more predicted aneuploidy alterations had a 5.3 times higher odds of lethal cancer during follow-up.
A new study found that children with inflammatory bowel disease, including ulcerative colitis and Crohn's disease, have a higher risk of developing cancer and dying early compared to the general population. The study suggests that cancer surveillance and mental health assessment are crucial for young patients with these conditions.
Researchers at Uppsala University found that inhibiting ribosome biogenesis can revert aggressive tumors to a non-invasive state, potentially regaining sensitivity to hormonal therapy. The study also showed a marked reduction in lung metastases.
A large study found that HER2 expression can predict DCIS recurrence and progression, enabling targeted treatments for high-risk patients. By screening DCIS patients for HER2, doctors can minimize the chance of recurrence or spread in lower-risk patients.
A study of 429 men with metastatic castration-resistant prostate cancer found correlations between specific genetic alterations and clinical outcomes. The loss of the RB1 tumor suppressor gene was significantly correlated with poor survival in patients treated with androgen receptor signaling inhibitors.
A new nomogram developed by researchers can accurately predict the likelihood of occult lymph node metastases in esophageal cancer. This tool may help clinicians identify high-risk patients who would benefit from neoadjuvant therapy, leading to more informed treatment discussions and potentially improved patient outcomes.
A study by Johns Hopkins Medicine and partners found that a simple performance evaluation letter can reduce unnecessary tissue removal in Mohs micrographic surgery for skin cancer. The intervention led to an improvement in surgical behavior, sustained for one year, with 83% of notified physicians reducing their practice.
Researchers found a truncated variant of the p53 protein, Δ40p53, forming amyloid aggregates in endometrial cancer cells. This finding promises new perspectives for treating Type 2 endometrial cancer, the most aggressive form of the disease.
Researchers have identified four hallmarks of cancer metastasis: motility, modulation of the microenvironment, plasticity, and ability to colonize. This understanding could lead to the development of new therapeutic interventions for this complex process, which is responsible for up to 90% of cancer deaths.
Researchers found that repeated detection of HPV DNA in oral rinses after cancer treatment was associated with a higher risk of cancer recurrence and death. The study suggests HPV DNA may be a promising biomarker for understanding cancer treatment response and future risk of progression.
Researchers at CNIO describe the RUVBL1-RUVBL2 ATPases as the 'energy engine' in the co-chaperone R2TP, regulating access to ATP for energy production. The study found a gate-like structure in RUVBL2 that controls energy exchange, coupled to the assembly of mTOR complexes.
The number of cardiologists trained in cardio-oncology is not meeting the growing needs of cancer survivors, who are aging and developing co-morbid cardiovascular disease. Limited training programs and resources are emerging to address this need, highlighting the importance of collaboration between cardiologists and oncologists.
A pilot program investigates human-animal interactions (HAIs) in reducing suffering of children with cancer undergoing debilitating treatments. Children are randomly assigned to a group receiving usual care or a group receiving HAI plus therapy dog visits.
Researchers at H. Lee Moffitt Cancer Center discovered a signaling pathway between cytokines and BRAF that promotes tumor growth. Blocking ITCH activity or BRAF ubiquitination may be an effective treatment approach to slow tumor growth in melanoma.
A deep-learning model developed using serial image scans of tumors from patients with non-small cell lung cancer (NSCLC) predicted treatment response and survival outcomes better than standard clinical parameters. The model's performance improved with the addition of each follow-up scan, predicting two-year survival with an accuracy of...
The article discusses the potential of liquid biopsy in cancer diagnosis, focusing on targeted disease diagnosis and detection of cancer biomarkers. Researchers have successfully detected specific genetic mutations using digital PCR, identifying promising biomarkers for various cancers, including melanoma and lung squamous cell carcinoma.
Researchers identified UNC45A as a key player in cancer cell proliferation and tumor growth. Inhibiting UNC45A was found to decrease cancer cell proliferation and cause mitotic catastrophe, leading to cell death.
Researchers have discovered that amplifying the amount of VGLL3 in skin cells pushes the immune system into overdrive, leading to autoimmune responses. This finding may help explain why women are more likely to develop autoimmune diseases like lupus and could lead to new treatments.
Scientists identified a molecular driver of glioblastoma, a highly aggressive and treatment-resistant brain cancer, by analyzing cell-by-cell genetic data. Researchers found that reprogramming primitive oligodendrocyte progenitors into stem-like cells plays a key role in glioma initiation and progression.
A new study investigates the Auger effect in aromatic hydrocarbons, revealing that molecules with pi electrons have a lower double ionization threshold. This finding favors Auger decay over saturated hydrocarbons, with potential applications in cancer treatment and atomic identification.
Research shows that branched actin transmits information to cells about their environment and regulates growth, a mechanism that can be targeted to fight certain types of cancer. Inhibiting branched actin formation prevents the growth of melanoma cells, offering new therapeutic options.
Researchers have developed a gene editing approach that corrects over 80% of patient cells, targeting the COL7A1 gene mutation responsible for recessive dystrophic epidermolysis bullosa. The technique shows promise for treating this rare disease with high efficiency and safety.
A new study has revealed a previously unknown interaction between proteins that causes certain types of cancer called sarcoma. The research, led by Pierre Åman, found that tumor-altered FET proteins bind to the SWI/SNF complex, leading to misregulation and disruptions in genetic programming.
Scientists at the Institut Pasteur have identified a cellular protein that can degrade hepatitis B virus DNA, potentially leading to a 'Trojan horse' approach to target infected liver cells. This discovery offers new hope for developing curative treatments for chronic HBV infection.
Rising liver cancer death rates in the US are largely confined to individuals with lower educational attainment, particularly men. The study highlights the need for targeted efforts to address the growing burden of liver cancer in lower socioeconomic groups.
Scientists developed a new imaging technology to visualize what cells eat, such as glucose, which could aid in the diagnosis and treatment of diseases like cancer. The technique uses chemical probes that light up when they attach to specific molecules consumed by cells.
A new study found that continued smoking by patients with cancer adds significant costs to subsequent cancer treatment. The analysis conservatively suggests a total of nearly $11,000 in increased treatment costs for each smoking patient after their initial cancer treatment fails.
A study published in JAMA Network Open found that continued smoking after a cancer diagnosis increases the risk of cancer treatment failure and adds $11,000 to treatment costs per patient. The research estimates $3.4 billion in national additional cancer treatment costs if patients continue to smoke.
A recent commentary suggests that treatment guidelines recommended by medical specialist organizations are more likely to lead to overdiagnosis, overtreatment, and increased healthcare costs. The authors argue that specialty bias and fee-for-service compensation models contribute to this issue.
Researchers have unraveled the three-dimensional structure of ATP citrate lyase (ACLY), a central metabolic enzyme crucial for fatty acid and cholesterol production. The study's findings provide new insights into ACLY's role in metabolism, evolution, and potential therapeutic targeting of cancer and metabolic diseases.
Researchers found that chronic morphine treatment decreased survival in control mice, but not in sickle mice with sickle cell disease. Chronic opioid therapy also caused hyperalgesia, a condition of increased pain sensitivity, in sickle mice. The study suggests that opioids may still be effective for managing pain in SCD patients despi...
Lauren Sciences LLC has received an AU$1 million grant from FightMND to advance its development of LAUR-301, a novel V-Smart Nanomedicine for ALS. The therapy aims to protect motor neurons and induce neuro-restoration, slowing or reversing the disease.
A study of almost 276,000 children found a small association between IVF conception and an increased risk of childhood cancer, mostly rare tumor types. The link was limited to the first decade of life and was found in only a subset of cancers.
The Cancer Control and Survivorship Program at St. Jude Children's Research Hospital has been awarded the 13th annual AACR Team Science Award for its innovative research advancing childhood cancer treatment and long-term survival outcomes. The program's work has significantly contributed to our understanding of pediatric cancer epidemi...
Scientists found that current WHO guidelines for chronic hepatitis B fail to detect 50% of patients in need of treatment in Ethiopia. The guidelines are based on European and American data, highlighting the need for regionalized approaches to identify patients with significant liver disease.
Researchers at the Garvan Institute of Medical Research have developed a new diagnostic method that screens cancer samples for 'fusion genes', which are linked to one in five cancers. The test identifies 20% more fusion genes than current methods, potentially leading to personalized treatments.
A preclinical study found that combining CAR T-cell therapy with photothermal ablation suppressed melanoma tumor growth for up to 20 days in mice. Among the treated mice, 33% remained tumor-free after 20 days.
A new study shows that uterine fibroid embolization (UFE) is as effective as surgical treatment in treating uterine fibroids, with fewer post-procedure complications. UFE preserves the uterus and allows women to return to their normal lives sooner.
The study found that the percentage of younger women initiating bisphosphonate treatment decreased over the 12-year period, while older women and those with osteopenia or osteoporosis increased. The overall percentage of osteoporosis among white and Asian women also rose.
Researchers have developed a more precise gene-editing technique to reduce DNA breaks and prevent cancer in stem cells. This breakthrough could improve the safety of CRISPR treatments for inherited blood disorders.
A recent study by Cancer Research UK reveals that African-American cancer patients with inherited red blood cell conditions are 20% more likely to experience serious adverse events. This disparity may be attributed to the rigors of therapy and the disproportionately higher incidence of these disorders in the African-American population.
A new study found that keeping blood pressure around 130 mm Hg for three years significantly reduced the accumulation of harmful brain lesions compared to maintaining a higher systolic blood pressure. This reduction also led to fewer major cardiovascular events, such as heart attacks and strokes.
Guidelines issued by North American specialty societies recommend health services linked to their specialties, differing from European guidelines. This phenomenon, known as 'specialty bias,' may exacerbate healthcare costs and worsen patient outcomes.
A new study reveals that patients with prostate, bladder, or kidney cancers who have had psychiatric care prior to treatment are at a greater risk of dying. The research also found an increased suicide risk among these patients, even after adjusting for previous mental health treatment.
Researchers have found that testosterone replacement therapy reduces prostate cancer recurrence in low-risk patients by nearly three-fold over three years. This study challenges the long-held notion that testosterone promotes prostate cancer and suggests a potential new treatment approach for these patients.
A new diagnostic tool has been developed to detect ovarian cancer earlier, with high sensitivity and specificity rates. The test uses liquid biopsy proteomics to identify unique protein signatures in uterine fluid, promising improved detection rates for young women at high risk of developing the disease.
Research links early menopause to increased bladder cancer risk, particularly in smokers. The study found that women who went into menopause before the age of 45 were 45% more likely to develop bladder cancer than those who had later menopause.
A new study reveals that the development of progenitor cells depends on protein quantity and interaction with other cells. Cells with high P120ctn expression remain in the central part of the pancreas, while those with low expression migrate to the peripheral area, where they acquire their final fate.
Researchers have identified a major mutation pattern in human cancer that occurs in bursts, with the cause of these mutational bursts remaining mysterious. The study, published in Cell, provides a vast resource for investigating the biological mechanisms behind cancer mutations.
A VA study evaluated quality indicators for hormone therapy in menopausal women and found that nearly 40% of prescriptions were inconsistent with evidence-based guidelines. The study suggests that point-of-care information and decision support are needed to ensure patients receive guideline-adherent care.
A diet rich in green tea and carrot compounds reversed Alzheimer's-like symptoms in mice, supporting the idea that plant-based supplements might offer protection against dementia. Combination therapy is suggested as a potential approach to treating the disease.
Researchers at University of Utah Health have developed a novel treatment that delays the onset of type 1 diabetes in mice and halts the progression of paralysis in multiple sclerosis models. The treatment targets misfunctioning immune cells, leaving normal immune cells intact.
The article highlights the challenges in predicting and stratifying cardiovascular risk in women due to sex-specific factors, traditional risk models' flaws, and inadequate representation of women in CVD research. This has led to a persistent gap in awareness, diagnosis, and treatment of ischemic heart disease in women.
Peripartum cardiomyopathy (PPCM) is a disorder where heart failure develops during or after pregnancy. Recent studies suggest angiogenic imbalance plays a key role, with soluble fms-like tyrosine kinase-1 (sFlt1) and prolactin being important factors. The latest IPAC study recommendations are also referenced.
A global modelling study estimates nearly 400,000 new cases of childhood cancer annually, while current records count only around 200,000. Undiagnosed cases could account for more than half of the total in Africa, South Central Asia and the Pacific Islands.
A recent study reports radiation contamination at an Arizona crematorium following treatment of a patient with a radioactive drug. The contamination was detected on equipment and in the operator's urine, raising concerns about potential health effects.
Patients living with HIV have equal access to optimal cancer therapy, according to a recent study in the journal CANCER. The findings challenge traditional beliefs that HIV infection is a contraindication for intensive cancer treatment.